Spinal Cord InjuriesNCT05811884
Patient-centered Assessment of the Effects of Powered Exoskeleton Use in People With Spinal Cord Injury
A study testing Rehabilitation in people with Spinal Cord Injuries, run by Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro at 1 site in Italy.
Trial summary
The goal of this clinical trial is to assess the efficacy of the use of powered exoskeleton for ambulation on the quality of life in subjects with spinal cord injury. The main questions it aims to answer are: 1. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Spinal Cord Injuries
- What is being tested?
- Rehabilitation
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 18 participants
- Where
- 1 siteItaly
- Study dates
- Jan 2030to Feb 2033
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Assisted by Inail;
- Age between 18 and 65 years;
- Body weight lower than 113 Kg;
- Level of spinal lesion T4 and higher;
- Integrity of upper limbs (strength and range of motion assessed by a clinical operator);
- Abbreviated Injury Scale (AIS) score A or B;
- Number of months after lesion higher than 6;
- Anthropometry in conformity with the declarations of exoskeleton's manufacturers.
Who cannot join
- Use of the powered exoskeleton in the last 6 months (in this case a wash-out phase is required);
- Use of colostomy bag;
- The subject is pregnant/ nursing;
- Presence of cognitive impairments;
- Presence of severe neurologic lesions in addition to SCI (sclerosis, cerebral palsy or trauma,…);
- Severe comorbidities;
Show all 15Show fewer
- Uncontrolled hypertension or orthostatic hypotension;
- Uncontrolled autonomic dysreflexia;
- Problems at the skeletal system: T-score of femoral neck lower than -3 (DEXA examination is required), bone mineral density of proximal tibia or distal femur lower than 0.6 g/cm2, presence of non-recovered fractures, ectopic ossification, unstable spine;
- Kinesiologic impairments of the lower limbs: Ashworth spasticity of hamstrings, quadriceps, gastrocnemius muscles (right/ left) lower than 4, uncontrolled clonic spasm, pathologic contractures: non conformity of the range of motion of ankle/ knee/ hip with the requisites for use of powered exoskeletons for ambulation, presence of pressure lesions, dysmetria: femurs higher than 1.5 cm/ tibias higher than 2 cm;
- Kinesiologic impairments of the upper limbs: limitations at the joints, weakness of shoulder/ elbow/ hand (manual evaluation by a clinician), no autonomy in transfers;
- Weak control of the trunk;
- Inability to stand for at least 30 minutes;
- Presence of joint prostheses in upper and lower limbs;
- Use of drugs that may affect cognition and coordination while using the exoskeleton.
Trial locations and contacts
1 site in 1 country.
About this study
The goal of this clinical trial is to assess the efficacy of the use of powered exoskeleton for ambulation on the quality of life in subjects with spinal cord injury. The main questions it aims to answer are:
- How much does the use of powered exoskeleton improve the quality of life in subjects with spinal cord injury after a 24 months treatment period in a house context (treatment 1) or in a clinical setting (treatment 2)?
- How much do the two treatments differ in terms of cost-utility ratio?
Read more
Participants will be included in a multi-step process consisting of:
- Recruitment, based on eligibility criteria;
- Observation of the "stability" over time (2 months) of specific clinical parameters;
- Training in the use of the powered exoskeleton (1 month);
- Random selection of the rehabilitation treatment (house rehabilitation or central rehabilitation); concerning the house rehabilitation, the subject will be provided the device for home use; concerning the central rehabilitation, the subject will be asked to use intensively the device 1-week every three months in a clinical facility.
- Follow-up: every six months each subject will be asked to attend a single-day activities session consisting of walking activities with the exoskeleton, compilation of questionnaires, sub-maximal effort test with arm-ergometer, and physical examinations made by a physiatrist.
- Conditions
- Spinal Cord Injuries
- Being tested
- Rehabilitation
- Medical subject headings
- Spinal Cord Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
RehabilitationDevice
The subjects will be provided of the powered exoskeleton for home use. No specific indications will be provided, but using the technology as much as possible.
The subjects will be asked to attend to periodic rehabilitation sessions by the clinical facility. The rehabilitation session will consist in an intense 1-week activities session every three months.
Every six months, the subjects will be asked to attend a single-day session by the clinical facility (follow-up session) consisting on the assessement of a series of qualitative and quantitative measurements.
| Study group | Role | What they receive |
|---|---|---|
| House rehabilitation | Experimental | The subjects will be provided of the powered exoskeleton for home use. No specific indications will be provided, but using the technology as much as possible.
Every six months, the subjects will be asked to attend a single-day session by the clinical facility (follow-up session) consisting on the assessement of a series of qualitative and quantitative measurements. Receives: Device: Rehabilitation |
| Central rehabilitation | Experimental | The subjects will be asked to attend to periodic rehabilitation sessions by the clinical facility. The rehabilitation session will consist in an intense 1-week activities session every three months. Every six months, the subjects will be asked to attend a single-day session by the clinical facility (follow-up session) consisting on the assessement of a series of qualitative and quantitative measurements. Receives: Device: Rehabilitation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in quality of life (QoL)
Short Form-36 questionnaire (SF-36): Generic health status measure. It applies to all health conditions and contains 36 items, divided in 8 domains. The higher the score, the higher the QoL.
Measured: This outcome will be assessed at the baseline and immediately after the intervention
Secondary outcomes (15)
Incremental cost utility ratio (ICUR) associated to the treatment
Incremental cost utility ratio (ICUR) associated to the treatment: it provides healthcare decision- makers and providers with a straightforward information, that is, how much a "unit of utility improvement" would cost them and/or the society. Assuming a timeframe of analysis and two alternative technologies or treatments A and B, ICUR is the ratio between the difference in costs and the difference in utility of A and B
Measured: This outcome will be assessed immediately after the intervention
Incidence of Treatment-Emergent Adverse Events assessed by self-report and extracted from the medical records
Incidence of major adverse events related to the exoskeleton use: falls, bone fractures, skin lesions, pressure lesions, cardiovascular events
Measured: This outcome will be assessed immediately after the intervention
Active use assessed by the number of strides and steps performed with the exoskeleton.
Strides and steps performed with the exoskeleton are counted automatically by the exoskeleton system. This parameters can be monitored by connecting to the exoskeleton system via a proprietary software.
Measured: This outcome will be assessed immediately after the intervention.
Change in usability assessed by the System Usability Scale (SUS) questionnaire
The SUS evaluates the usability of the assistive technology. It consists in 10 items with five response options for respondents, from Strongly agree to Strongly disagree. The participant's scores for each question are converted to a new number, added together and then multiplied by 2.5 to convert the original scores of 0-40 to 0-100. The higher the score, the higher the usability.
Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in satisfaction assessed by the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST) questionnaire
The QUEST evaluates a person's satisfaction with the assistive technology. It yields three scores: (i) Device, (ii) Services, and (iii) a total QUEST score. (i) consists of 10 items with five response options for respondents, from Strongly agree to Strongly disagree; the score is calculated by averaging the valid item responses; score range: 1-5. (ii) consists of 4 items with five response options for respondents, from Strongly agree to Strongly disagreeare; the score is calculated by averaging the valid item responses; score range: 1-5. (iii) is calculated by averaging the score of (i) and (ii). The QUEST presents a final section where the participants must indicate the three most important features of the technology.
Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in mental status assessed by the Patient Health Questionnaire-9 (PHQ-9) questionnaire
The PHQ-9 aims at identifying probable major depressive disorder among adult primary care patients. It consists in 9 items with four response options for respondents, from Never to Almost always. The final score is calculated by summing the valid item responses. Score range: 0 -27. The higher the score, the higher the level of depression.
Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in mental status assessed by the General Anxiety Disorder Scale (GAD-7) questionnaire
The GAD-7 assesses participant's anxiety. It consists of 7 items with four response options for respondents, from Never to Almost always. The final score is calculated by summing the valid item responses. Score range: 0 -21. The higher the score, the higher the level of anxiety.
Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in fitness level assessed by the Metabolic Equivalents of Tasks (METs) associated to the consumption of oxygen (VO2) during a sub-maximal arm crank ergometer test
The VO2 consumption is measured with a metabolic system throughout an exercise protocol with an arm-ergometer. According to previous study protocols, the VO2 consumption in the last 30 seconds of the arm-ergometer test are used to estimate the peak of VO2 consumption. After, this value is converted in METs.
Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in muscular spasticity assessed by the Modified Ashworth Scale (MAS)
The MAS assesses the resistance to passive range of motion about a single joint with a 6-point rating scale. It's performed by extending the patients limb first from a position of maximal possible flexion to maximal possible extension ( the point at which the first soft resistance is met). Afterwards, the modified Ashworth scale is assessed while moving from extension to flexion. The higher the score, the higher the muscular spasticity. The scores can assume the following values: 0 - No increase in tone;1 - slight increase in tone giving a catch when slight increase in muscle tone, manifested by the limb was moved in flexion or extension; 1+ - slight increase in muscle tone, manifested by a catch followed by minimal resistance throughout the range of motion; 2 -more marked increase in tone but more marked increased in muscle tone through most limb easily flexed; 3 - considerable increase in tone, passive movement difficult; 4 - limb rigid in flexion or extension.
Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in integrity of the rotator cuff muscles assessed by Jobe's test and Speed's test
The Jobe's test aids in diagnosing rotator cuff tears or subacromial impingement. The examiner passively elevates the patient's shoulder to 90 degrees of abduction with internal rotation. The examiner then applies a downward pressure against the arm. A positive test is the provocation of pain or abnormal weakness.
The Speed's test is used to test for superior labral tears or bicipital tendonitis. To perform the Speed's Test, the examiner places the patient's arm in shoulder flexion, external rotation, full elbow extension, and forearm supination; manual resistance is then applied by the examiner in a downward direction. The test is considered to be positive if pain in the bicipital tendon or bicipital groove is reproduced In both test, the exerted force will be also measured using a dynamometer.
Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in self-care and independence assessed by the Spinal Cord Independence Measure (SCIM) questionnaire
The SCIM assesses of the ability of SCI patients to perform basic activities of daily living. It assesses three subscales: (i) self-care, (ii) respiration and sphincter management, and (iii) mobility. (i) consists in 6 items with four or five response options for respondents. Score range: 0-20. (ii) consists in 4 items with three to six response options for respondents. Score range: 0-40. (iii) consists in 8 items with three to nine response options for respondents. Score range: 0-40. Each subscale score is evaluated separately by summing the valid item responses. The higher the score, the higher the level of independence.
Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in pain assessed by Visual Analogue Scale (VAS)
The pain VAS is a unidimensional measure of pain intensity, used to record patients' pain progression. It consists in a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured (pain in this case) orientated from the left (worst) to the right (best).
Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in sphincter's functionality assessed by a 5-Likert scale
The 5-Likert scale consists of a single item which investigates the patients self-perceived sphincter's functionality, ranging from 1 (worst case) to 5 (best case)
Measured: This outcome will be assessed at the beginning of the trial and at each follow-up (every 6 months) until trial completion
Change in velocity during ambulation assessed by the 6 Minutes Walking Test (6 MWT)
The 6 MWT is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in velocity during ambulation assessed by the 10 Meters Walking Test (10 MWT)
The 10 MWT is a performance measure used to assess walking speed in meters per second over a short distance. It can be employed to determine functional mobility, gait, and vestibular function.
Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Apr 2023
- Study startJan 2030 (estimated)
- Primary completionJan 2033 (estimated)
- Study completionFeb 2033 (estimated)
Why it stopped: Financial issues
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Spinal Cord InjuriesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 18 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05811884
- Sponsor's protocol ID
- SSC DCAPR Prospettico
- Status last verified
- Apr 2025
- First submitted
- 16 Mar 2023
- Last updated
- 27 Mar 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Pseudonymized data could be shared upon request only
Study at a glance
From the registry record, last updated by the sponsor on 27 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Patient-centered Assessment of the Effects of Powered Exoskeleton Use in People With Spinal Cord Injury
- ClinicalTrials.gov ID
- NCT05811884
- Acronym / sponsor ID
- SSC DCAPR Prospettico
- Conditions
- Spinal Cord Injuries
- Study type
- Interventional
- Recruitment status
- SuspendedReason stopped: Financial issues
- Enrolment
- 18 participants (estimated)
- Lead sponsor
- Istituto Nazionale Assicurazione contro gli Infortuni sul LavoroUniversity, hospital or other
- Study start
- Jan 2030 (estimated)
- Primary completion
- Jan 2033 (estimated)
- Study completion
- Feb 2033 (estimated)
- First posted
- 13 Apr 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to assess the efficacy of the use of powered exoskeleton for ambulation on the quality of life in subjects with spinal cord injury. The main questions it aims to answer are:
- How much does the use of powered exoskeleton improve the quality of life in subjects with spinal cord injury after a 24 months treatment period in a house context (treatment 1) or in a clinical setting (treatment 2)?
- How much do the two treatments differ in terms of cost-utility ratio?
Participants will be included in a multi-step process consisting of:
- Recruitment, based on eligibility criteria;
- Observation of the "stability" over time (2 months) of specific clinical parameters;
- Training in the use of the powered exoskeleton (1 month);
- Random selection of the rehabilitation treatment (house rehabilitation or central rehabilitation); concerning the house rehabilitation, the subject will be provided the device for home use; concerning the central rehabilitation, the subject will be asked to use intensively the device 1-week every three months in a clinical facility.
- Follow-up: every six months each subject will be asked to attend a single-day activities session consisting of walking activities with the exoskeleton, compilation of questionnaires, sub-maximal effort test with arm-ergometer, and physical examinations made by a physiatrist.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| House rehabilitation | Experimental | Device: RehabilitationThe subjects will be provided of the powered exoskeleton for home use. No specific indications will be provided, but using the technology as much as possible. Every six months, the subjects will be asked to attend a single-day session by the clinical facility (follow-up session) consisting on the assessement of a series of qualitative and quantitative measurements. |
| Central rehabilitation | Experimental | Device: RehabilitationThe subjects will be asked to attend to periodic rehabilitation sessions by the clinical facility. The rehabilitation session will consist in an intense 1-week activities session every three months. Every six months, the subjects will be asked to attend a single-day session by the clinical facility (follow-up session) consisting on the assessement of a series of qualitative and quantitative measurements. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Assisted by Inail;
- Age between 18 and 65 years;
- Body weight lower than 113 Kg;
- Level of spinal lesion T4 and higher;
- Integrity of upper limbs (strength and range of motion assessed by a clinical operator);
Key exclusion criteria (15 listed)
- Use of the powered exoskeleton in the last 6 months (in this case a wash-out phase is required);
- Use of colostomy bag;
- The subject is pregnant/ nursing;
- Presence of cognitive impairments;
- Presence of severe neurologic lesions in addition to SCI (sclerosis, cerebral palsy or trauma,…);
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| RehabilitationThe subjects will be provided of the powered exoskeleton for home use. No specific indications will be provided, but using the technology as much as possible. The subjects will be asked to attend to periodic rehabilitation sessions by the clinical facility. The rehabilitation session will consist in an intense 1-week activities session every three months. Every six months, the subjects will be asked to attend a single-day session by the clinical facility (follow-up session) consisting on the assessement of a series of qualitative and quantitative measurements. | Device | Central rehabilitation, House rehabilitation |
Primary outcome
Change in quality of life (QoL)
Time frame: This outcome will be assessed at the baseline and immediately after the intervention
Short Form-36 questionnaire (SF-36): Generic health status measure. It applies to all health conditions and contains 36 items, divided in 8 domains. The higher the score, the higher the QoL.
15 secondary outcomes
Incremental cost utility ratio (ICUR) associated to the treatment
Time frame: This outcome will be assessed immediately after the intervention
Incidence of Treatment-Emergent Adverse Events assessed by self-report and extracted from the medical records
Time frame: This outcome will be assessed immediately after the intervention
Active use assessed by the number of strides and steps performed with the exoskeleton.
Time frame: This outcome will be assessed immediately after the intervention.
Change in usability assessed by the System Usability Scale (SUS) questionnaire
Time frame: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in satisfaction assessed by the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST) questionnaire
Time frame: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in mental status assessed by the Patient Health Questionnaire-9 (PHQ-9) questionnaire
Time frame: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in mental status assessed by the General Anxiety Disorder Scale (GAD-7) questionnaire
Time frame: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in fitness level assessed by the Metabolic Equivalents of Tasks (METs) associated to the consumption of oxygen (VO2) during a sub-maximal arm crank ergometer test
Time frame: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in muscular spasticity assessed by the Modified Ashworth Scale (MAS)
Time frame: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in integrity of the rotator cuff muscles assessed by Jobe's test and Speed's test
Time frame: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in self-care and independence assessed by the Spinal Cord Independence Measure (SCIM) questionnaire
Time frame: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in pain assessed by Visual Analogue Scale (VAS)
Time frame: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in sphincter's functionality assessed by a 5-Likert scale
Time frame: This outcome will be assessed at the beginning of the trial and at each follow-up (every 6 months) until trial completion
Change in velocity during ambulation assessed by the 6 Minutes Walking Test (6 MWT)
Time frame: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Change in velocity during ambulation assessed by the 10 Meters Walking Test (10 MWT)
Time frame: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Mar 2026.
- Individual participant dataSharing planned: No. Pseudonymized data could be shared upon request only
Related trials for Spinal Cord Injuries
Recruiting
MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury
Spinal Cord Injuries, Tetraplegia
Recruiting
Clinical Outcome Assessment for AT & BCI
Spinal Cord Injury, ALS (Amyotrophic Lateral Sclerosis)
Recruiting
Transcutaneous Spinal Cord Stimulation Combined With 4-Aminopyridine and Intensive Rehabilitation in SCI
Spinal Cord Injuries
Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Stroke, Parkinson's Disease (PD)
RecruitingPhase 3
A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord Injury
Chronic Spinal Cord Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Rehabilitation in people with Spinal Cord Injuries, run by Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: paused, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in quality of life (QoL) (time frame: This outcome will be assessed at the baseline and immediately after the intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.